Pharmaceutical Company Eli Lilly Caps Insulin Cost at $35 a Month
The pharmaceutical company Eli Lilly is capping the cost of insulin at $35 a month, a move that could help millions of Americans afford to pay for the life-saving medication. NBC10’s Miguel Martinez-Valle explains.